Medicare Enrolled
Dr. Tamar Brionez, MD
Rheumatology · The Woodlands, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brionez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brionez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brionez
Dr. Tamar Brionez is a rheumatology specialist in The Woodlands, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Brionez performed 37,360 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Brionez received a total of $146,464 from 60 pharmaceutical and/or device companies across 1046 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brionez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 26% volume in TX
$146,464 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗37,360
Medicare services
Top 26% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
23,600 | $4 | $15 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
9,950 | $34 | $130 |
| Denosumab injection (Prolia/Xgeva) | 2,280 | $18 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
268 | $89 | $200 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
219 | $1 | $16 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
169 | $20 | $150 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
154 | $47 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $66 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
133 | $10 | $46 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
122 | $93 | $337 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
79 | $4 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $120 | $250 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
48 | $54 | $152 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
41 | $12 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
27 | $30 | $50 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
27 | $4 | $25 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
22 | $76 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $76 | $150 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
11 | $49 | $122 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
28.0% high complexity
70.4% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$146,464
Total received (2018-2024)
Avg $20,923/year across 7 years
Top 6% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,046
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,672
2023
$11,322
2022
$21,508
2021
$26,078
2020
$23,602
2019
$44,286
2018
$7,995
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$6,361
Janssen Biotech, Inc.
$2,371
Biogen, Inc.
$970
AstraZeneca Pharmaceuticals LP
$687
Amgen Inc.
$257
ABBVIE INC.
$179
Janssen Scientific Affairs, LLC
$150
GENZYME CORPORATION
$146
UCB, Inc.
$56
SOBI, INC
$53
ANI Pharmaceuticals, Inc.
$51
E.R. Squibb & Sons, L.L.C.
$46
Lilly USA, LLC
$45
Sandoz Inc.
$43
GlaxoSmithKline, LLC.
$38
Radius Health, Inc.
$37
Aurinia Pharma U.S., Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
PFIZER INC.
$22
Kyowa Kirin, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$20
Alvogen Inc
$19
TerSera Therapeutics LLC
$19
Fidia Pharma USA Inc.
$17
Zimmer Biomet Holdings, Inc.
$16
Top 3 companies account for 83.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$32,213
AbbVie, Inc.
$19,877
AstraZeneca Pharmaceuticals LP
$14,778
UCB, Inc.
$13,265
ABBVIE INC.
$10,978
NOVARTIS PHARMACEUTICALS CORPORATION
$8,465
Janssen Biotech, Inc.
$8,426
Novartis Pharmaceuticals Corporation
$7,934
AbbVie Inc.
$7,355
Regeneron Pharmaceuticals, Inc.
$5,508
PFIZER INC.
$4,622
Lilly USA, LLC
$2,813
Amgen Inc.
$2,183
Horizon Therapeutics plc
$1,773
Biogen, Inc.
$970
GENZYME CORPORATION
$682
Mallinckrodt Hospital Products Inc.
$614
Radius Health, Inc.
$482
E.R. Squibb & Sons, L.L.C.
$408
Genentech USA, Inc.
$356
Janssen Scientific Affairs, LLC
$354
Celgene Corporation
$351
Mallinckrodt Enterprises LLC
$266
Alexion Pharmaceuticals, Inc.
$182
ANI Pharmaceuticals, Inc.
$154
Antares Pharma, Inc.
$116
Hikma Pharmaceuticals USA
$115
TerSera Therapeutics LLC
$91
SOBI, INC
$89
Sandoz Inc.
$76
AstraZeneca UK Limited
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$73
West-Ward Pharmaceuticals
$62
Octapharma USA, Inc.
$58
Aurinia Pharma U.S., Inc.
$47
Organon LLC
$47
Horizon Pharma plc
$46
Teva Pharmaceuticals USA, Inc.
$45
Ultragenyx Pharmaceutical Inc.
$44
Sobi, Inc
$39
Gilead Sciences, Inc.
$36
MEDAC PHARMA, INC.
$29
MEDEXUS PHARMA, INC.
$29
Ironwood Pharmaceuticals, Inc
$29
Mallinckrodt LLC
$25
Takeda Pharmaceuticals U.S.A., Inc.
$23
Mylan Institutional Inc.
$23
Actelion Pharmaceuticals US, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$22
Kyowa Kirin, Inc.
$21
SCILEX PHARMACEUTICALS INC.
$20
Abbott Laboratories
$19
Alvogen Inc
$19
Fresenius Kabi USA, LLC
$19
Exeltis, USA Inc.
$18
Fidia Pharma USA Inc.
$17
Celltrion USA Inc.
$16
Merck Sharp & Dohme Corporation
$16
Zimmer Biomet Holdings, Inc.
$16
Flexion Therapeutics, Inc.
$14
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Axium INS DRG IPG · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · EVENITY · EVUSHELD · Enbrel · FORTEO · Gel-One Cross-linked Hyaluronate · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Hulio · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Quzyttir · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Skyrizi · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Truxima · Tymlos · ULTOMIRIS · Uloric · Ultomiris · XELJANZ · XYOSTED · YUFLYMA · ZEPBOUND · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
28
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S THE WOODLANDS HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brionez is a mixed practice specialist, with above-average Medicare volume (top 26% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brionez experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Brionez performed 23,600 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Brionez receive payments from pharmaceutical companies?
Yes. Dr. Brionez received a total of $146,464 from 60 companies across 1,046 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brionez's costs compare to other rheumatologists in The Woodlands?
Dr. Brionez's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brionez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in The Woodlands
Browse rheumatologists in The Woodlands ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology